Reflections on the 1976 swine flu vaccination program
Open accessAbstract
In 1976, 2 recruits at Fort Dix, New Jersey, had an influenzalike illness.Isolates of virus taken from them included A/New Jersey/76 (Hsw1n1), a strain similar to the virus believed at the time to be the cause of the 1918 pandemic, commonly known as swine flu.Serologic studies at Fort Dix suggested that >200 soldiers had been infected and that person-to-person transmission had occurred.We review the process by which these events led to the public health decision to mass-vaccinate the American public against the virus and the subsequent events that led to the program's cancellation.Observations of policy and implementation success and failures are presented that could help guide decisions regarding avian influenza."Flu to the Starboard!Man the Harpoons!Fill with Vaccine!Get the Captain!Hurry!" Edwin D. Kilbourne, New York Times, February 13, 1976 (1) "Grounding a Pandemic" Barack Obama and Richard Lugar, New York Times, June 6, 2005 (2) Swine Flu at Fort DixOn February 3, 1976, the New Jersey State Health Department sent the Center for Disease Control (CDC) in Atlanta isolates of virus from recruits at Fort Dix, New Jersey, who had influenzalike illnesses.Most of the isolates were identified as A/Victoria/75 (H3N2), the contemporary epidemic strain.Two of the isolates, however, were not typeable in that laboratory.On February 10, additional isolates were sent and identified in CDC laboratories as A/New Jersey/76 (Hsw1N1), similar to the virus of the 1918 pandemic and better known as "swine flu."A meeting of representatives of the military, the National Institute of Health, the Food and Drug Administration (FDA), and the State of New Jersey Department of Health was quickly convened on Saturday, February 14, 1976.Plans of action included heightened surveillance in and around Fort Dix, investigation of the ill recruits to determine if contact with pigs had occurred, and serologic testing of recruits to determine if spread had occurred at Fort Dix.Surveillance activities at Fort Dix gave no indication that recruits had contact with pigs.Surveillance in the surrounding communities found influenza caused by the current strain of influenza, A/Victoria, but no additional cases of swine flu.Serologic testing at Fort Dix indicated that person-to-person transmission had occurred in >200 recruits (4).In 1974 and 1975, 2 instances of humans infected with swine influenza viruses had been documented in the United States.Both persons involved had close contact with pigs, and no evidence for spread of the virus beyond family members with pig contact could be found (5). The National Influenza Immunization ProgramOn March 10, 1976, the Advisory Committee on Immunization Practices of the United States Public Health Service (ACIP) reviewed the findings.The committee concluded that with a new strain (the H1N1 New Jersey strain) Reflections on the 1976 Swine Flu Vaccination Program
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
False alarms about emerging infectious diseases can be politically costly, as seen in the 1976 H1N1 influenza scare and the 2009 H1N1 pandemic, which had a relatively low mortality rate of 0.1-0.7%.
“There is no doubt that false alarms about emerging infectious diseases can be politically costly, as was seen during the H1N1 influenza scare in 1976—an epidemic that never occurred91, 92—and the 2009 H1N1 influenza pandemic, which ultimately had a relatively low mortality rate of 0·1–0·7%.93”
From The Lancet Commission on lessons for the future from the COVID-19 pandemic (2022) · cites this paper as [91]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Fraser, D. W., Tsai, T. F., Orenstein, W. A., Parkin, W. E., Beecham, H. J., Sharrar, R. G., Harris, J., Mallison, G. F., Martin, S. M., McDade, J. E., et al. (1977) · New England Journal of Medicine · doi:10.1056/nejm197712012972201 · Cited by 1,706 · see citing works
Guillain-Barr� syndrome: Its epidemiology and associations with influenza vaccination
Schonberger, L. B., Hurwitz, E. S., Katona, P. G., Holman, R. C., & Bregman, D. J. (1981) · Annals of Neurology · doi:10.1002/ana.410090707 · Cited by 98 · see citing works
Schoenbaum, S. C., McNeil, B. J., & Kavet, J. (1976) · New England Journal of Medicine · doi:10.1056/nejm197609302951405 · Cited by 97 · see citing works
Influenza Pandemic Periodicity, Virus Recycling, and the Art of Risk Assessment
Dowdle, W. R. (2006) · Emerging infectious diseases · doi:10.3201/eid1201.051013 · Cited by 68 · see citing works
Hodder, R. A., Gaydos, J. C., Allen, R. G., Top, F. H., Nowosiwsky, T., & Russell, P. K. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.supplement_3.s369 · Cited by 56 · see citing works
Swine Influenza Virus Infections in Humans
Dowdle, W. R., & Hattwick, M. A. W. (1977) · The Journal of Infectious Diseases · doi:10.1093/infdis/136.supplement_3.s386 · Cited by 55 · see citing works
Swine-like influenza vaccine: A commentary
Denny, F. W., Glezen, W. P., Karzon, D. T., Katz, S. L., Krugman, S., McIntosh, K., & Parrott, R. H. (1976) · The Journal of Pediatrics · doi:10.1016/s0022-3476(76)81077-3 · Cited by 2 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus
Hancock, K., Veguilla, V., Lu, X., Zhong, W., Butler, E. N., Sun, H., Liu, F., Dong, L., DeVos, J. R., Gargiullo, P. M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0906453 · Cited by 1,260 · see citing works
The Pathology of Influenza Virus Infections
Taubenberger, J. K., & Morens, D. M. (2008) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathmechdis.3.121806.154316 · Cited by 1,111 · see citing works
The Lancet Commission on lessons for the future from the COVID-19 pandemic
Sachs, J. D., Karim, S. S. A., Aknin, L., Allen, J., Brosbøl, K., Colombo, F., Barron, G. C., Espinosa, M. F., Gaspar, V., Gaviria, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01585-9 · Cited by 842 · see citing works
Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
Greenberg, M. E., Lai, M. H., Härtel, G., Wichems, C. H., Gittleson, C., Bennet, J. K., Dawson, G., Hu, W., Leggio, C., Washington, D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0907413 · Cited by 491 · see citing works
Influenza: The Once and Future Pandemic
Taubenberger, J. K., & Morens, D. M. (2010) · Public Health Reports · doi:10.1177/00333549101250s305 · Cited by 346 · see citing works
Schwarzinger, M., Flicoteaux, R., Cortarenoda, S., Obadia, Y., & Moatti, J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010199 · Cited by 245 · see citing works
Centers for Disease Control and Prevention
Thacker, S. B., Sencer, D. J., Jaffe, H. W., Gantt, J. M., & Hilpertshauser, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99967-0.00160-5 · Cited by 208 · see citing works
Self-citationGuillain-Barré syndrome after exposure to influenza virus
Lehmann, H. C., Hartung, H., Kieseier, B. C., & Hughes, R. A. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70140-7 · Cited by 199 · see citing works
Manicassamy, B., Medina, R., Hai, R., Tsibane, T., Stertz, S., Nistal‐Villán, E., Palese, P., Basler, C. F., & García‐Sastre, A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000745 · Cited by 197 · see citing works
Vírseda, S., Restrepo, M. A., Arranz, E., Tapia, P. M., Fernández‐Ruiz, M., de la Cámara, A. G., Aguado, J. M., & López‐Medrano, F. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.101 · Cited by 142 · see citing works
Infectious and noninfectious triggers in Guillain–Barré syndrome
Wakerley, B. R., & Yuki, N. (2013) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2013.811119 · Cited by 137 · see citing works
Novel swine-origin influenza A virus in humans: another pandemic knocking at the door.
Michaelis, M., Doerr, H. W., & Cinatl, J. (2009) · Medical Microbiology and Immunology · doi:10.1007/s00430-009-0118-5 · Cited by 127 · see citing works
Vellozzi, C. J., Broder, K. R., Haber, P., Guh, A. Y., Nguyen, M., Cano, M. V., Lewis, P., McNeil, M. M., Bryant, M., Singleton, J. A., et al. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.09.021 · Cited by 125 · see citing works
The First Pandemic of the 21st Century: Review of the 2009 Pandemic Variant Influenza A (H1N1) Virus
Scalera, N. M., & Mossad, S. B. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.09.2051 · Cited by 118 · see citing works
Australian Quarantine Policy: From Centralization to Coordination with Mid‐Pandemic COVID‐19 Shifts
Moloney, K., & Moloney, S. (2020) · Public Administration Review · doi:10.1111/puar.13224 · Cited by 116 · see citing works
Pandemic influenza: certain uncertainties
Morens, D. M., & Taubenberger, J. K. (2011) · Reviews in Medical Virology · doi:10.1002/rmv.689 · Cited by 110 · see citing works
Bangerter, A., Krings, F., Mouton, A., Gilles, I., Green, E. G. T., & Clémence, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049806 · Cited by 108 · see citing works
Schwarzinger, M., Verger, P., Guerville, M.-A., Aubry, C., Rolland, S., Obadia, Y., & Moatti, J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.01.027 · Cited by 100 · see citing works
Wise, M. E., Viray, M. A., Sejvar, J. J., Lewis, P., Baughman, A. L., Connor, W., Danila, R., Giambrone, G. P., Hale, C. R., Hogan, B., et al. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws196 · Cited by 94 · see citing works
Adverse Consequences of Rushing a SARS-CoV-2 Vaccine
Trogen, B., Oshinsky, D. M., & Caplan, A. L. (2020) · JAMA · doi:10.1001/jama.2020.8917 · Cited by 92 · see citing works
Evans, D., Cauchemez, S., & Hayden, F. G. (2009) · The Journal of Infectious Diseases · doi:10.1086/603560 · Cited by 91 · see citing works
Wang, Z. (2009) · JAMA · doi:10.1001/jama.2009.265 · Cited by 90 · see citing works
Deaths following vaccination: What does the evidence show?
Miller, E. R., Moro, P. L., Cano, M. V., & Shimabukuro, T. T. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.05.023 · Cited by 88 · see citing works
Response after One Dose of a Monovalent Influenza A (H1N1) 2009 Vaccine — Preliminary Report
Greenberg, M. E., Lai, M. H., Härtel, G., Wichems, C. H., Gittleson, C., Bennet, J. K., Dawson, G., Hu, W., Leggio, C., Washington, D., et al. (2009) · Cited by 83 · see citing works
Implications of the Emergence of a Novel H1 Influenza Virus
Belshe, R. B. (2009) · New England Journal of Medicine · doi:10.1056/nejme0903995 · Cited by 72 · see citing works
Influenza Pandemic Periodicity, Virus Recycling, and the Art of Risk Assessment
Dowdle, W. R. (2006) · Emerging infectious diseases · doi:10.3201/eid1201.051013 · Cited by 68 · see citing works
McCullers, J. A., de Velde, L.-A. V., Allison, K., Branum, K. C., Webby, R. J., & Flynn, P. M. (2010) · Clinical Infectious Diseases · doi:10.1086/652441 · Cited by 67 · see citing works
Gao, L., Yu, S., Chen, Q., Duan, Z., Zhou, J., Mao, C., De-xian, Y., Zhu, W., Nie, J., & Hou, Y. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.03.062 · Cited by 64 · see citing works
Kim, P. S., Jang, Y. H., Kwon, S. Y., Lee, C., Han, G., & Seong, B. L. (2018) · Viruses · doi:10.3390/v10040183 · Cited by 64 · see citing works
Back to WHAT? The role of research ethics in pandemic times
Solbakk, J. H., Bentzen, H. B., Holm, S., Heggestad, A. K. T., Hofmann, B., Robertsen, A., Alnæs, A. H., Cox, S., Pedersen, R., & Bernabe, R. (2020) · Medicine Health Care and Philosophy · doi:10.1007/s11019-020-09984-x · Cited by 55 · see citing works
Immunogenicity of Avian Influenza A/Anhui/01/2005(H5N1) Vaccine With MF59 Adjuvant
Belshe, R. B., Frey, S. E., Graham, I. L., Anderson, E. L., Jackson, L. A., Spearman, P. W., Edupuganti, S., Mulligan, M. J., Rouphael, N., Winokur, P. L., et al. (2014) · JAMA · doi:10.1001/jama.2014.12609 · Cited by 54 · see citing works
Experience and lessons from surveillance and studies of the 2009 pandemic in Europe
Nicoll, A., Ammon, A., Amato, A., Ciancio, B. C., Zucs, P., Devaux, I., Plata, F., Mazick, A., Mølbak, K., Asikainen, T., et al. (2010) · Public Health · doi:10.1016/j.puhe.2009.12.001 · Cited by 54 · see citing works
INFLUENZA EXPOSURE IN UNITED STATES FERAL SWINE POPULATIONS
Hall, J. S., Minnis, R. B., Campbell, T. A., Barras, S. C., DeYoung, R. W., Pabilonia, K. L., Avery, M. L., Sullivan, H. J., Clark, L. C., & McLean, R. G. (2008) · Journal of Wildlife Diseases · doi:10.7589/0090-3558-44.2.362 · Cited by 51 · see citing works
Influenza vaccination and Guillain–Barré syndrome: Reality or fear
Babazadeh, A., Afshar, Z. M., Javanian, M., Mohammadnia‐Afrouzi, M., Karkhah, A., Masrour-Roudsari, J., Sabbagh, P., Koppolu, V., Vasigala, V. R., & Ebrahimpour, S. (2019) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2019-0028 · Cited by 51 · see citing works
Eick, A. A., Wang, Z., Hughes, H., Ford, S. M., & Tobler, S. K. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.03.088 · Cited by 49 · see citing works
Hampson, A. W. (2008) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.v37n6p510 · Cited by 49 · see citing works
Mackenzie, I. S., MacDonald, T. M., Shakir, S., Dryburgh, M., Mantay, B. J., Mcdonnell, P. J., & Layton, D. (2011) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2011.04142.x · Cited by 47 · see citing works
Al‐Kuwari, M. G., Aziz, N. A., Nazzal, Z. A. S., & Al-Nuaimi, S. A. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.08.093 · Cited by 45 · see citing works
Swine Influenza Virus Infections in Man
Krueger, W. S., & Gray, G. C. (2012) · Current topics in microbiology and immunology · doi:10.1007/82_2012_268 · Cited by 42 · see citing works
Zheng, B. Q., Zhang, Y., He, H., Marinova, E., Switzer, K. C., Wansley, D. L., Mbawuike, I. N., & Han, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.9.6153 · Cited by 42 · see citing works
Thacker, S. B., Sencer, D. J., & Jaffe, H. W. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803678-5.00057-6 · Cited by 40 · see citing works
Self-citationThe Future of Influenza Vaccines: A Historical and Clinical Perspective
Bouvier, N. M. (2018) · Vaccines · doi:10.3390/vaccines6030058 · Cited by 41 · see citing works
Taiwan’s Annual Seasonal Influenza Mass Vaccination Program—Lessons for Pandemic Planning
Meyer, D., Shearer, M. P., Chih, Y.-C., Hsu, Y.-C., Lin, Y.-C., & Nuzzo, J. B. (2018) · American Journal of Public Health · doi:10.2105/ajph.2018.304527 · Cited by 39 · see citing works
Khazeni, N., Hutton, D. W., Garber, A. M., & Owens, D. K. (2009) · Annals of Internal Medicine · doi:10.7326/0000605-200912150-00156 · Cited by 39 · see citing works
Kash, J. C., Qi, L., Dugan, V. G., Jagger, B. W., Hagey, R. J., Memoli, M. J., Morens, D. M., & Taubenberger, J. K. (2010) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2010.00132.x · Cited by 38 · see citing works
Influenza pandemics: past, present and future challenges
Flahault, A., & Zylberman, P. (2010) · Public health reviews · doi:10.1007/bf03391605 · Cited by 37 · see citing works
WAISBREN, B. A. (2007) · Medical Hypotheses · doi:10.1016/j.mehy.2007.04.043 · Cited by 35 · see citing works
Reeth, K. V., & Nicoll, A. (2009) · Eurosurveillance · doi:10.2807/ese.14.07.19124-en · Cited by 34 · see citing works
Parida, R., Shaila, M. S., Mukherjee, S., Chandra, N. R., & Nayak, R. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.08.044 · Cited by 32 · see citing works
Verger, P., Flicoteaux, R., Schwarzinger, M., Sagaon‐Teyssier, L., Peretti‐Watel, P., Launay, O., Sebbah, R., & Moatti, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041837 · Cited by 32 · see citing works
Guillain-Barré Syndrome Following Influenza Vaccination: Causal or Coincidental?
Sejvar, J. J., Pfeifer, D., & Schonberger, L. B. (2011) · Current Infectious Disease Reports · doi:10.1007/s11908-011-0194-8 · Cited by 30 · see citing works
Xie, H., Li, X., Gao, J., Lin, Z., Xu, J., Plant, E. P., Zoueva, O., Eichelberger, M. C., & Ye, Z. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir693 · Cited by 30 · see citing works
Skin Immunization with Influenza Vaccines
Skountzou, I., & Compans, R. W. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_407 · Cited by 28 · see citing works
Moving the needle on racial disparity: COVID-19 vaccine trust and hesitancy
Lin, C., Tu, P., & Terry, T. C. (2021) · Vaccine · doi:10.1016/j.vaccine.2021.11.010 · Cited by 28 · see citing works
Chambers, J., Barker, K., & Rouse, A. (2012) · Health & Place · doi:10.1016/j.healthplace.2011.06.005 · Cited by 27 · see citing works
Vaccination against influenza: role and limitations in pandemic intervention plans
Rebmann, T., & Zelicoff, A. P. (2012) · Expert Review of Vaccines · doi:10.1586/erv.12.63 · Cited by 27 · see citing works
Swine and Influenza: A Challenge to One Health Research
Kahn, R. E., Ma, W., & Richt, J. A. (2014) · Current topics in microbiology and immunology · doi:10.1007/82_2014_392 · Cited by 27 · see citing works
Kelso, J. M. (2012) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e328354395d · Cited by 24 · see citing works
Evaluating the safety of influenza vaccine using a claims-based health system
McCarthy, N. L., Gee, J. M., Lin, N. D., Hoffman, V., Pan, Y., Su, S., Turnbull, B., Chan, K. A., & Weintraub, E. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.031 · Cited by 23 · see citing works
Choe, Y. J., Cho, H., Kim, S. N., Bae, G., & Lee, J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.129 · Cited by 22 · see citing works
Halpin, A. L., Gu, W., Wise, M. E., Sejvar, J. J., Hoekstra, R. M., & Mahon, B. E. (2018) · Epidemiology and Infection · doi:10.1017/s0950268818001802 · Cited by 22 · see citing works
Immunogenicity of influenza A(H1N1)pdm09 vaccine in patients with diabetes mellitus
Egawa, Y., Ohfuji, S., Fukushima, W., Yamazaki, Y., Morioka, T., Emoto, M., Maeda, K., Inaba, M., & Hirota, Y. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.28252 · Cited by 20 · see citing works
Aflunov®: a prepandemic influenza vaccine
Gasparini, R., Amicizia, D., Lai, P. L., & Panatto, D. (2012) · Expert Review of Vaccines · doi:10.1586/erv.11.170 · Cited by 20 · see citing works
Perspective: Swine-Origin Influenza: 1976 and 2009
Sencer, D. J. (2010) · Clinical Infectious Diseases · doi:10.1093/cid/ciq006 · Cited by 20 · see citing works
Self-citationAvian Influenza: a global threat needing a global solution
Koh, G., Wong, T., Cheong, S., & Koh, D. S. Q. (2008) · Asia Pacific Family Medicine · doi:10.1186/1447-056x-7-5 · Cited by 20 · see citing works
Zika virus epidemic: an update
Valentine, G. C., Marquez, L., & Pammi, M. (2016) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2016.1245614 · Cited by 18 · see citing works
Another emerging arbovirus, another emerging vaccine: Targeting Zika virus
Palácios, R., Poland, G. A., & Kalil, J. E. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.03.059 · Cited by 17 · see citing works
Influenza virus surveillance in migratory ducks and sentinel ducks at Poyang Lake, China.
Duan, L., Zhu, H., Wang, J., Huang, K., Cheung, C.-L., Peiris, J. S. M., Chen, H., & Guan, Y. (2011) · PubMed · Cited by 17 · see citing works
Swine flu update: bringing home the bacon
Senanayake, S. (2009) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02721.x · Cited by 17 · see citing works
The Importance of Context in Covid-19 Vaccine Safety
Lee, G. M. (2021) · New England Journal of Medicine · doi:10.1056/nejme2112543 · Cited by 17 · see citing works
The 1918–20 Influenza Pandemic
Athukorala, P., & Athukorala, C. (2022) · Cambridge University Press eBooks · doi:10.1017/9781009336062 · Cited by 16 · see citing works
Promoting conspiracy theory: From AIDS to COVID-19
Nattrass, N. (2023) · Global Public Health · doi:10.1080/17441692.2023.2172199 · Cited by 16 · see citing works
Guillain-Barré-Syndrom nach Exposition mit Influenza
Hartung, H., Keller‐Stanislawski, B., Hughes, R. A., & Lehmann, H. C. (2012) · Der Nervenarzt · doi:10.1007/s00115-012-3479-8 · Cited by 15 · see citing works
Novel Influenza A (H1N1) Outbreak On Board a US Navy Vessel
Dill, C. E., & Favata, M. A. (2009) · Disaster Medicine and Public Health Preparedness · doi:10.1097/dmp.0b013e3181bf249b · Cited by 15 · see citing works
Igari, H., Segawa, S., Watanabe, A., Suzuki, A., Watanabe, M., Sakurai, T., Kuroda, F., Watanabe, M., Tatsumi, K., Nakayama, M., et al. (2010) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2010.00254.x · Cited by 15 · see citing works
Swine Flu and Travelers: An Australian Perspective
Leggat, P. A., Speare, R., & Aitken, P. J. (2009) · Journal of Travel Medicine · doi:10.1111/j.1708-8305.2009.00372.x · Cited by 15 · see citing works
The influenza pandemic and Europe: the social impact and public health response
Paget, J. (2009) · Italian Journal of Public Health · doi:10.2427/5781 · Cited by 15 · see citing works
Extreme Evolutionary Conservation of Functionally Important Regions in H1N1 Influenza Proteome
Warren, S., Wan, X., Conant, G. C., & Korkin, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081027 · Cited by 14 · see citing works
Time evolution of predictability of epidemics on networks
Holme, P., & Takaguchi, T. (2015) · Physical Review E · doi:10.1103/physreve.91.042811 · Cited by 14 · see citing works
Microbiome First Approaches to Rescue Public Health and Reduce Human Suffering
Dietert, R. R. (2021) · Biomedicines · doi:10.3390/biomedicines9111581 · Cited by 14 · see citing works
Trust, terrorism and public health
McKee, M., & Coker, R. (2009) · Journal of Public Health · doi:10.1093/pubmed/fdp091 · Cited by 14 · see citing works
Faix, D. J., Hawksworth, A. W., Myers, C. A., Hansen, C. J., Ortiguerra, R. G., Halpin, R., Wentworth, D. E., Pacha, L. A., Schwartz, E. G., Garcia, S. M. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034581 · Cited by 13 · see citing works
Responding to Vaccine Safety Signals during Pandemic Influenza: A Modeling Study
Maro, J. C., Fryback, D. G., Lieu, T. A., Lee, G. M., & Martin, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115553 · Cited by 13 · see citing works
Usefulness of simulated cases for assessing pandemic influenza preparedness plans
Cardeñosa, N., Domı́nguez, Á., Carratalà, J., Ricarte, J. I., Jansà, J. M., Arnau, J., Camps, N., Chanovas, M. R., Mas, A., & Trilla, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03144.x · Cited by 13 · see citing works
Lee, H., Heo, N., Kwon, D., & Ha, J. (2022) · BMJ Neurology Open · doi:10.1136/bmjno-2022-000378 · Cited by 12 · see citing works
Vaccination and 30-Day Mortality Risk in Children, Adolescents, and Young Adults
McCarthy, N. L., Gee, J. M., Sukumaran, L., Weintraub, E., Duffy, J., Kharbanda, E. O., Baxter, R. P., Irving, S. A., King, J. P., Daley, M. F., et al. (2016) · PEDIATRICS · doi:10.1542/peds.2015-2970 · Cited by 12 · see citing works
Quelling Public Fears About Guillain-Barré Syndrome and COVID-19 Vaccination
BOURDETTE, D. N., & Killestein, J. (2021) · Neurology · doi:10.1212/wnl.0000000000011882 · Cited by 12 · see citing works
Nicholson, K. G., Abrams, K. R., Batham, S., Clark, T., Höschler, K., Lim, W. S., Medina, M. A. M., Nguyen‐Van‐Tam, J. S., Read, R. C., Warren, F. C., et al. (2010) · Health Technology Assessment · doi:10.3310/hta14550-04 · Cited by 11 · see citing works
Neurologic Safety Monitoring of COVID-19 Vaccines
Thakur, K. T., Epstein, S., Bilski, A. E., Balbi, A. M., Boehme, A. K., Brannagan, T. H., Wesley, S. F., & Riley, C. (2021) · Neurology · doi:10.1212/wnl.0000000000012703 · Cited by 11 · see citing works
An update on emerging therapeutics to combat COVID‐19
Shah, N. N., Nabi, S. U., Rather, M. A., Kalwar, Q., Ali, S. I., Sheikh, W. M., Ganai, A., & Bashir, S. M. (2021) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13600 · Cited by 10 · see citing works
In favour of a bespoke COVID-19 vaccines compensation scheme
Fairgrieve, D., Holm, S., Howells, G. G., Kirchhelle, C., & Vanderslott, S. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00065-7 · Cited by 11 · see citing works
A influência da resposta dos EUA à COVID-19 no contexto da Saúde Global
Leineweber, F. V., & Bermudez, J. A. Z. (2021) · Ciência & Saúde Coletiva · doi:10.1590/1413-81232021263.38042020 · Cited by 9 · see citing works
The Great Influenza Pandemic of 1918–20: An interpretative survey in the time of COVID-19
Athukorala, P., & Athukorala, C. (2020) · Working Paper Series · doi:10.35188/unu-wider/2020/881-8 · Cited by 9 · see citing works
Pre-emptive vaccination against pandemic influenza virus
Montomoli, E., & Manini, I. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.11.026 · Cited by 9 · see citing works
Influenza vaccination: lessons learned from the pandemic (H1N1) 2009 influenza outbreak
Openshaw, P., & Dunning, J. W. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.34 · Cited by 9 · see citing works
Thacker, S. B., & Sencer, D. J. (2008) · Elsevier eBooks · doi:10.1016/b978-012373960-5.00303-8 · Cited by 9 · see citing works
Self-citationA preliminary panorama of the diversity of N1 subtype influenza viruses
Chen, J., Ma, H.-C., Chen, J.-W., Sun, Y.-X., Li, J., & Wang, Z.-L. (2006) · Virus Genes · doi:10.1007/s11262-006-0025-4 · Cited by 8 · see citing works
Barriers to Vaccinating the Elderly With H1N1 Vaccine
Brown, J., Goebel, L. J., Neitch, S. M., Mufson, M. A., & Tweel, H. K. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31820e782b · Cited by 7 · see citing works
Cihan, F. G., Durmaz, F. G., Odabaş, D., Baydemır, C., & Kaçar, F. (2012) · Postgraduate Medicine · doi:10.3810/pgm.2012.11.2602 · Cited by 7 · see citing works
Avian and swine influenza viruses
Tang, C. Y., Ramesh, A. K., & Wan, X. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-818619-0.00093-9 · Cited by 5 · see citing works
- Authors
- Sencer, D. J., & Millar, J. D.
- Affiliations
- Atlanta, Georgia, USA;
- Murraysville, Georgia, USA
- Corresponding author
- Sencer, David J.
- Venue
- Emerging Infectious Diseases
- Published
- 2006-01
- Volume
- 12
- Issue
- 1
- Pages
- 23-28
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- PMC
- PMC3291400
- OpenAlex
- W2101877224
- Cited by
- 163
- References
- 7
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 4 · 2023: 6 · 2022: 7 · 2021: 13 · 2020: 8 · 2019: 3 · 2018: 7 · 2017: 3 · 2016: 7 · 2015: 4 · 2014: 8 · 2013: 4 · 2012: 12
- FWCI
- 9.07
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Emerging infectious diseases (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Social Sciences › Sociology and Political Science › Global Security and Public Health
- Keywords
- influenza vaccination program, influenza surveillance, human-to-human transmission, vaccine adverse events, vaccine hesitancy, public health decision-making, pandemic influenza preparedness
- MeSH terms
- Animals, Decision Making, Humans, Influenza, Human, Influenza Vaccines, Male, National Health Programs, New Jersey, Influenza A virus, United States, Guillain-Barre Syndrome, Mass Vaccination, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review